48
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Long-term Effects of Losartan on Proteinuria and Renal Function in Patients with Renal Amyloidosis

, , , , , & show all
Pages 443-446 | Published online: 09 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Michael Haidinger, Johannes Werzowa, Renate Kain, Marlies Antlanger, Manfred Hecking, Stefan Pfaffenberger, Julia Mascherbauer, Thomas Gremmel, Janet A. Gilbertson, Dorota Rowczenio, Thomas Weichhart, Chantal Kopecky, Walter H. Hörl, Philip N. Hawkins & Marcus D. Säemann. (2013) Hereditary amyloidosis caused by R554L fibrinogen Aα-chain mutation in a Spanish family and review of the literature. Amyloid 20:2, pages 72-79.
Read now
Aysun Aybal Kutlugün, Bulent Altun, Umit Aktan, Ercan Turkmen, Mahmut Altindal, Tolga Yildirim, Rahmi Yilmaz, Mustafa Arici, Yunus Erdem & Cetin Turgan. (2012) The relation between urinary angiotensinogen and proteinuria in renal AA amyloidosis patients. Amyloid 19:1, pages 28-32.
Read now
Elizabeth Ripley & Ari Hirsch. (2010) Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?. International Journal of Nephrology and Renovascular Disease 3, pages 93-98.
Read now
Serdar Kahvecioglu, Ibrahim Akdag, Mustafa Gullulu, Mahmut Arabul, Alpaslan Ersoy, Kamil Dilek, Mahmut Yavuz & Mustafa Yurtkuran. (2007) Comparison of Higher Dose of Losartan Treatment with Losartan Plus Carvedilol and Losartan Plus Ramipril in Patients with Glomerulonephritis and Proteinuria. Renal Failure 29:2, pages 169-175.
Read now

Articles from other publishers (5)

S. Georgin-Lavialle, L. Savey, D. Buob, J.-P. Bastard, S. Fellahi, A. Karras, J.-J. Boffa & G. Grateau. (2023) French practical guidelines for the diagnosis and management of AA amyloidosis. La Revue de Médecine Interne 44:2, pages 62-71.
Crossref
Riccardo Papa & Helen J. Lachmann. (2018) Secondary, AA, Amyloidosis. Rheumatic Disease Clinics of North America 44:4, pages 585-603.
Crossref
Yavuz Ayar, Alparslan Ersoy, Mustafa Ferhat Oksuz, Gokhan Ocakoglu, Berna Aytac Vuruskan, Abdülmecit Yildiz, Emel Isiktas, Aysegül Oruc, Sedat Celikci, Ismail Arslan, Ahmet Bilgehan Sahin & Mustafa Güllülü. (2017) Clinical outcomes and survival in AA amyloidosis patients. Revista Brasileira de Reumatologia (English Edition) 57:6, pages 535-544.
Crossref
Yavuz Ayar, Alparslan Ersoy, Mustafa Ferhat Oksuz, Gokhan Ocakoglu, Berna Aytac Vuruskan, Abdülmecit Yildiz, Emel Isiktas, Aysegül Oruc, Sedat Celikci, Ismail Arslan, Ahmet Bilgehan Sahin & Mustafa Güllülü. (2017) Desfechos clínicos e sobrevida em pacientes com amiloidose AA. Revista Brasileira de Reumatologia 57:6, pages 535-544.
Crossref
SERDAR KAHVECIOGLU, KAMIL DILEK, IBRAHIM AKDAG, MUSTAFA GULLULU, CELALETTIN DEMIRCAN, ALPASLAN ERSOY & MUSTAFA YURTKURAN. (2006) Effect of indomethacin and selective cyclooxygenase‐2 inhibitors on proteinuria and renal function in patients with AA type renal amyloidosis. Nephrology 11:3, pages 232-237.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.